Pharmacokinetics of dolutegravir 100 mg once daily with rifampicin.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2019.04.009
Abstract: BACKGROUND Tuberculosis (TB) causes 25% of all deaths among individuals infected with human immunodeficiency virus (HIV). Rifampicin (RIF) is a potent inducer of drug metabolizing enzymes and drug transporters, and co-administration with dolutegravir (DTG) reduces… read more here.
Keywords: rifampicin; 100 daily; dtg 100; c24h ... See more keywords